PTGX vs RL · rev $269.8M vs P/E 24, rev $8.11B
Protagonist Therapeutics Inc (PTGX) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
PTGX currently screens at market cap $7.25B. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the PTGX and RL stock pages for the full models.
Not investment advice.